The Medical Expenditure Panel Survey (MEPS) is a set of
large-scale surveys of families and individuals, their medical
providers, and employers across the United States. MEPS is the most complete
source of data on the cost and use of health care and health insurance
coverage. Learn more about MEPS.
New Publications Research Findings 49: Pre-COVID-19 Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID-19. The coronavirus pandemic is placing unprecedented strains on our health care system, including novel uses of medications to treat people with COVID-19. We identified a list of COVID-19-relevant drugs from published sources and present estimates of average annual total users, total fills, total expenditures, fills per user, and expenditures per user for each drug. We use this information to present the percent distribution of conditions associated with drugs that were subsequently used to treat COVID-19.
Under New Data Files The MEPS HC-213A: 2019 Prescribed Medicines File provides detailed information on household-reported prescribed medicines for a nationally representative sample of the civilian noninstitutionalized population of the United States and can be used to make estimates of prescribed medicine utilization and expenditures for calendar year 2019.
Under New Data Files The
1996-2019 MEPS Link Files to NHIS documentation contains a cross-walk that will
enable data users to merge the MEPS Full-Year Population Characteristics PUF, or similarly,
the MEPS Full-Year Consolidated PUF, with the NHIS prior two data years person-level PUFs
that contain data collected for MEPS respondents in the year prior to their initial year
of MEPS participation. For reasons of confidentiality, the MEPS/NHIS link files are
available only through the AHRQ Data Center
To access a list of all the latest items posted on our Web site,
visit What's New.
Back
Email Updates
